Evidence map›Paper›PMID 32989128›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Metabolic precision labeling enables selective probing of O-linked

Marjoke F Debets, Omur Y Tastan, Simon P Wisnovsky, Stacy A Malaker, Nikolaos Angelis, Leonhard K R Moeckl, Junwon Choi, Helen Flynn, Lauren J S Wagner, Ganka Bineva-Todd and 17 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Bifunctional Monosaccharides Preferentially Localize to Nuclear Subcompartments.Chembiochem : a European journal of chemical biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. A Bioorthogonal Precision Tool for HumanJournal of the American Chemical Society · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 2 countries.

Marjoke F DebetsDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0002-5176-0072
Omur Y TastanThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0003-2604-766X
Simon P WisnovskyDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Stacy A MalakerDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0003-2382-5067
Nikolaos AngelisStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0002-5149-7665
Leonhard K R MoecklDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Junwon ChoiDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Helen FlynnProteomics Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0001-7002-9130
Lauren J S WagnerDepartment of Chemistry, University of California, Berkeley, CA 94720.ORCID 0000-0002-8532-7496
Ganka Bineva-ToddThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0001-8926-9417
Aristotelis AntonopoulosDepartment of Life Sciences, Imperial College London, SW7 2AZ London, United Kingdom.
Anna CioceThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
William M BrowneThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0003-2647-3714
Zhen LiThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
David C BriggsSignalling and Structural Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Holly L DouglasMycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0002-2669-8852
Gaelen T HessDepartment of Genetics, Stanford University, Stanford, CA 94305.
Anthony J AgbayDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0003-0466-5977
Chloe RoustanStructural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Svend KjaerStructural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Stuart M HaslamDepartment of Chemistry, Imperial College London, W12 0BZ London, United Kingdom.
Ambrosius P SnijdersProteomics Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Michael C BassikDepartment of Genetics, Stanford University, Stanford, CA 94305.
W E MoernerDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0002-2830-209X
Vivian S W LiStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, CA 94305.ORCID 0000-0003-4482-2754
Benjamin SchumannThe Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom; b.schumann@imperial.ac.uk.ORCID 0000-0001-5504-0147
The Francis Crick Institute · GBStanford University · USImperial College London · GBHoward Hughes Medical Institute · USUniversity of California, Berkeley · US

Funding

Single-Molecule Imaging for Cell Biology and Super-Resolution MicroscopyR35GM118067 · NIGMS · STANFORD UNIVERSITY · PI MOERNER, WILLIAM E · 2016 to 2025
$6.2M
Investigating the Surface GlycoproteomeR01CA200423 · NCI · STANFORD UNIVERSITY · PI Carolyn Bertozzi · 2015 to 2026
$3.8M
An enzymatic approach to study cancer-associated cell-surface glycoproteins: exploration of mucin-degrading bacterial metalloproteasesF32GM126663 · NIGMS · STANFORD UNIVERSITY · PI MALAKER, STACY ALYSE · 2017 to 2019
$125k
Biotechnology and Biological Sciences Research Council BB/F008309/1Cancer Research UK FC001105Cancer Research UK FC001115Cancer Research UK FC001749CIHRHoward Hughes Medical InstituteMedical Research Council FC001105Medical Research Council FC001115Medical Research Council FC001749NCI NIH HHS R01 CA200423NIGMS NIH HHS F32 GM126663NIGMS NIH HHS R35 GM118067Wellcome Trust 104785/B/14/ZWellcome Trust FC001105Wellcome Trust FC001115Wellcome Trust FC001749
6 · The paper itself

Abstract

Protein glycosylation events that happen early in the secretory pathway are often dysregulated during tumorigenesis. These events can be probed, in principle, by monosaccharides with bioorthogonal tags that would ideally be specific for distinct glycan subtypes. However, metabolic interconversion into other monosaccharides drastically reduces such specificity in the living cell. Here, we use a structure-based design process to develop the monosaccharide probe

Indexed as

AcetylgalactosamineGene Expression Regulation, EnzymologicGlycoproteinsGlycosylationHumansRacemases and EpimerasesSubstrate SpecificityUridine Diphosphate N-AcetylgalactosamineAcetylgalactosamineGlycoproteinsRacemases and EpimerasesUridine Diphosphate N-Acetylgalactosaminebioorthogonalglycosylationglycosyltransferasemucin

Identifiers

PMID32989128
PMCPMC7568240
OpenAlexW3089626965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.